5 Tiger Global Myriad Genetics Trades
Tiger Global started to build up the position in Myriad Genetics in Q4 2013 and continued to invest until Q1 2014. Since then they sold 2.35M shares. The investor completely sold their stake between Q2 2014 and Q2 2015.
News about Myriad Genetics, Inc. and Tiger Global
Collaboration between Myriad Genetics and Memorial Sloan Kettering Cancer Center to Explore MRD Testing in Breast Cancer
Myriad Genetics, Inc. has recently announced an exciting collaboration with Memorial Sloan Kettering Cancer Center (MSK) to delve into the realm of minimal r...
Myriad Genetics to Participate in Goldman Sachs Healthcare Conference
SALT LAKE CITY, June 07, 2023 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. , (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced...
Global DNA Sequencing Strategic Business Report 2023: Increasing Emphasis on Personalized Medicine Drives Market Growth
3 Gene Editing Stocks With the Best Long-Term Potential
Gene editing stocks present themselves as one of the more lucrative investments in the healthcare sector. Gene editing, a revolutionary take on the science o...